EUVEIN 500 Film-coated tablet (2021)
Βιβλιογραφική αναφορά
Για την προβολή της πλήρους καταχώρησης απαιτείται συνδρομή σε ισχύ.
Αποκτήστε πρόσβαση σε όλες τις πληροφορίες και τα εργαλεία του Galinos.gr δωρεάν για έναν μήνα απλά κάνοντας εγγραφή.
Δωρεάν εγγραφή
Αποκτήστε πρόσβαση σε όλες τις πληροφορίες και τα εργαλεία του Galinos.gr δωρεάν για έναν μήνα απλά κάνοντας εγγραφή.
Δωρεάν εγγραφή
Περιεχόμενα
1. Name of the medicinal product
Euvein 500 Film Coated Tablet.
2. Qualitative and quantitative composition
Each film-coated tablets contains 500 mg of Micronized Flavonoids which is equivalent to Diosmin 450 mg + Hesperidin 50 mg and excipients which includes, Sodium Lauryl Sulfate, Microcrystalline cellulose ...
3. Pharmaceutical form
Brown, oval, slightly convex, film coated tablets.
4.1. Therapeutic indications
Euvein 500 Film Coated Tablet is a phlebotonic that increases the venous tone and protects the vessels. Treatment of symptoms related to venolymphatic insufficiency (heavy legs, pain,nocturnal cramps). ...
4.2. Posology and method of administration
Dosage Usual dose in chronic conditions 2 tablets daily in two divided doses morning and evening at mealtimes. In acute hemorrhoidal attacks 6 tablets daily (in 3 divided doses) for 3 to 4 days, then 4 ...
4.3. Contraindications
Euvein 500 Film Coated Tablet is contraindicated to patients hypersensitive to any substance contained in the drug.
4.4. Special warnings and precautions for use
If symptom of acute hemorrhoidal attack do not improve or worsen within 2 weeks, please consult your doctor. Euvein 500 Film Coated Tablet should not be administered during the first three months of pregnancy. ...
4.5. Interaction with other medicinal products and other forms of interaction
Interactions regarding the administration of Euvein 500 Film Coated Tablet with other drugs or substance have not been reported.
4.6. Pregnancy and lactation
There are limited data on safety use of this drug in pregnant women or nursing women, it should be used with care and under supervision of the physician. Euvein should not be administered during the first ...
4.8. Undesirable effects
Like all medicines, Euvein can cause side effects, although not everybody gets them. <u>Common (≤10%):</u> Gastrointestinal side effects (diarrhea, dyspepsia, nausea, vomiting) <u>Uncommon (≤1%):</u> Colitis ...
4.9. Overdose
IN CASE OF OVERDOSE IT IS NECESSARY TO ASK FOR YOUR PHYSICIANS OR PHARMACISTS ADVICE.
5.1. Pharmacodynamic properties
Venotonic and vascular protector. Pharmacology It is active upon the return vascular system in the following way: it reduces venous distensibility and stasis, in the microcirculation, it normalises capillary ...
5.2. Pharmacokinetic properties
In man, following oral administration of the substance containing Euvein: excretion is mainly faecal, a mean of 14% of the dose administered is excreted in the urine. the elimination half-life is 11 hours. ...
6.1. List of excipients
Sodium lauryl sulfate Microcrystalline cellulose Colloidal silicon dioxide Sodium starch glycolate Magnesium stearate Talcum HPMC E15 Ethylcellulose Polyethylene glycol 6000 Magnesium carbonate Titanium ...
6.3. Shelf life
Do not use after expiry date stated on the packaging.
6.4. Special precautions for storage
Euvein 500 Film Coated Tablet should be stored at below 30ºC in a cool dry place. <b>Warning!</b> Keep out of reach of children. All information on this leaflet refers only to your Physicians prescribed ...
6.5. Nature and contents of container
Film coated tablets in PVC/aluminum blisters. Each box contains 30 tablets presented in 10 tablets per blister together with a patient information leaflet.
7. Marketing authorization holder
Manufacturer: General Drugs House Co.,Ltd., 2-4 Lardprao Road Soi 82, Bangkok, Thailand 10310
10. Date of revision of the text
16 June 2021
Πηγαίο έγγραφο
Το πηγαίο έγγραφο για αυτήν την βιβλιογραφική αναφορά είναι διαθέσιμο προς μεταφόρτωση:
